Autoantibodies are central to the diagnosis, classification, and stratification of many autoimmune diseases, particularly ...

A research team at Catholic University of Daegu has developed a treatment candidate that suppresses blood cancer cell growth ...

Researchers at The University of Texas MD Anderson Cancer Center identified an immune pathway that may promote the ...

Despite the presence of oxygen, tumors frequently preferentially perform fermentative glycolysis, producing lactate and acidifying the tumor microenvironment. Although studies have observed that high ...

A previous trial involving patients with metastatic prostate cancer that was resistant to androgen pathway modulation (formerly referred to as castration-resistant) showed that adding talazoparib to ...

ABNORMAL Wnt signalling appears to drive the development of a rare and high-risk form of childhood liver cancer, according to new research. The study focused on hepatoblastomas with carcinoma (HBCs) ...

Editor's note: James Van Der Beek died on Feb. 11, 2026, his wife, Kimberly, shared on Instagram. She did not share a cause of death. Van Der Beek had been battling colon cancer since August 2023. He ...

Laboratory studies suggest cinnamon’s bioactive compounds can alter key cancer-related signaling pathways, but researchers caution that human trials are essential before any preventive or therapeutic ...

Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites seeding new resistant tumors elsewhere in the body. Combating the problem has ...

A large, multi-institution study led by a Brown University physician-scientist could have important implications for the development of new classes of cancer therapeutics. PROVIDENCE, R.I. [Brown ...

Combined androgen blockade shows significant survival benefits over single-agent ADT in high-risk prostate cancer, as demonstrated by the PRESTO, EMBARK, and ENZARAD trials. The PRESTO trial ...